The AARP Public Policy Institute determined that nearly 60% of American seniors take at least one prescription drug on a regular basis. The average senior takes four medications on a regular basis. According to an AARP report, retail prices for a combined set of widely used prescription drugs consistently increased faster than general inflation in every year from 2006 to 2013, the last year for which full data are available. The average annual retail cost of widely used specialty prescription drugs was over $53,000 in 2013, more than twice the $23,500 median income of Medicare beneficiaries.
Astronomically priced drugs are making everyone sick, but Maryland seniors are particularly vulnerable to endless substantial escalations in their prescription drug costs. AARP is actively working on ways to help make prescription drugs affordable for its members and all Americans, and we believe bill HB 631/SB 415 is a good start. AARP strongly supports prescription drug transparency bill HB 666/SB 437, with penalties for noncompliance, furnishes for high-cost drugs. Let your legislators know you support laws that keep drug prices low and drug companies transparent in why they are choosing to raise prices.
Marylanders deserve affordable prescription drugs
Dear [Decision Maker],
I am writing you today to express my support of HB631/SB415, as well as HB666/SB437. These bills will require major drug companies to disclose the basis of their drug prices, provide public notice prior to a major price increase, and authorize the Maryland Attorney General to take legal action to prevent prescription drug price gouging.
Sincerely,[Your Name] [Your Address] [City, State ZIP]